🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and tolerability of single and multiple doses of SYH...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Nanjing University Medical School
Start Date
2026-01-10
Trial ID
NCT07736391
Treatments Being Tested
This is a the first in human study to evaluate the safety, tolerability, PK...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2020-08-27
Trial ID
NCT04511624
Treatments Being Tested
This study is designed to assess tolerability of the weight-adjusted dose o...
Status
Completed
Location
The Lindner Research Center
Start Date
2019-02-18
Trial ID
NCT03844191
Treatments Being Tested
A dose-block randomized, double-blind, placebo-controlled, single and multi...
Status
Completed
Location
Seoul National University Clinical Trial Center
Start Date
2022-12-20
Trial ID
NCT05980065
The purpose of Part 1 of this study is to evaluate the safety and tolerabil...
Status
Terminated
Location
Arizona Oncology Associates, PC - HOPE
Start Date
2012-12
Trial ID
NCT01727336
Treatments Being Tested
This is an interventional, randomized, parallel group, treatment, Phase IIb...
Status
Completed
Location
Investigative Site Number: 1018
Start Date
2021-12-13
Trial ID
NCT05131477
Treatments Being Tested
This is a multi-center, randomized, two-part (Part A and Part B) study inve...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-07-22
Trial ID
NCT07704892
Treatments Being Tested
This randomized controlled trial aims to assess whether treatment with deno...
Status
Completed
Location
Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine
Start Date
2024-03-01
Trial ID
NCT06300229
Treatments Being Tested
This randomized phase 3 trial is studying the effect of denosumab to see if...
Status
Terminated
Location
Research Site
Start Date
2010-06-02
Trial ID
NCT01077154
The main purpose of this study is to investigate whether dupilumab is effec...
Status
Completed
Location
Regeneron study Site
Start Date
2020-10-28
Trial ID
NCT04206553
Treatments Being Tested